Melatonin and Jet Lag: What Do Clinical Trials Actually Say?

In our knowledge-base entry on melatonin, we describe it as a pineal gland hormone regulating the circadian rhythm, whose natural secretion rises in the evening, signaling to the body that bedtime is approaching. Jet lag — circadian rhythm desynchronization after rapidly crossing several time zones — is one of the few contexts where melatonin's mechanism of action is unusually direct and easy to test experimentally: administered at the right time, it can attempt to "reset" the internal biological clock faster than it would adjust on its own to the new time zone.

This directness of mechanism is exactly why jet lag became one of the first and best-studied applications of melatonin, well-studied enough to earn its own systematic Cochrane review — an institution that applies some of the most rigorous evidence-evaluation standards in all of medicine.

The starting point is the now-classic systematic review by Herxheimer and Petrie, published in the Cochrane database, covering randomized trials comparing melatonin to placebo in the context of relieving jet lag symptoms.

To check whether the Cochrane conclusion held up in light of later literature, it's worth turning to the 2015 umbrella review by Tortorolo and colleagues, systematically summarizing several independent systematic reviews on the same topic.

One of the most important, practical observations from the Cochrane review concerns dosing: different doses in the range of 0.5 to 5 mg showed similar effectiveness, suggesting that in this specific application, it's not the dose amount but the timing relative to the target time zone that determines effectiveness. This makes sense given melatonin's mechanism of action — as a signal synchronizing the biological clock, not a sedative acting proportionally to dose.

This is important, practical information for anyone reaching for melatonin intuitively, assuming "more means better" — the available data doesn't support this in this specific application, and higher doses only carry a greater risk of excessive drowsiness at the wrong moment, without additional benefit.

In practice, this means someone planning a flight across several time zones might consider a small dose of melatonin (0.5-5 mg), taken close to the planned bedtime in the new time zone, as one of the better-documented, over-the-counter strategies for relieving jet lag — without needing to reach for high doses.

Melatonin for jet lag is one of the rare cases in supplement science where the evidence is simultaneously strong and comes mainly from one specific, though no longer young, source — the Cochrane review. It's worth knowing both facts at once: the strength of the effect and the age of the evidentiary foundation, rather than treating this topic as either "freshly confirmed" or, conversely, "outdated and unreliable."

For someone planning a longer trip across several time zones, a small dose of melatonin taken at the right time remains one of the better-documented, easily accessible strategies — but it's worth treating it as one element of a broader time-zone adjustment strategy, not the only solution.